BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24011385)

  • 1. Vascular endothelial growth factor concentrations in dogs with spirocercosis.
    Mukorera V; Kirberger RM; Mabeta P; Dvir E
    J Vet Intern Med; 2013; 27(6):1642-5. PubMed ID: 24011385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma IL-8 concentrations are increased in dogs with spirocercosis.
    Dvir E; Mellanby RJ; Kjelgaard-Hansen M; Schoeman JP
    Vet Parasitol; 2012 Nov; 190(1-2):185-90. PubMed ID: 22770706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of selected growth factor expression in canine spirocercosis (Spirocerca lupi)-associated non-neoplastic nodules and sarcomas.
    Dvir E; Clift SJ
    Vet Parasitol; 2010 Dec; 174(3-4):257-66. PubMed ID: 20888695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum alkaline phosphatase activity is not a marker for neoplastic transformation of esophageal nodules in canine spirocercosis.
    Mukorera V; van der Merwe LL; Lavy E; Aroch I; Dvir E
    Vet Clin Pathol; 2011 Sep; 40(3):389-92. PubMed ID: 21790698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum C-reactive protein concentration in benign and malignant canine spirocercosis.
    Mukorera V; Dvir E; van der Merwe LL; Goddard A
    J Vet Intern Med; 2011; 25(4):963-6. PubMed ID: 21615495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hemostatic abnormalities in canine spirocercosis and its association with systemic inflammation.
    Pazzi P; Goddard A; Kristensen AT; Dvir E
    J Vet Intern Med; 2014; 28(1):21-9. PubMed ID: 24147754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum acute phase protein concentrations in dogs with spirocercosis and their association with esophageal neoplasia - a prospective cohort study.
    Nivy R; Caldin M; Lavy E; Shaabon K; Segev G; Aroch I
    Vet Parasitol; 2014 Jun; 203(1-2):153-9. PubMed ID: 24656552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical characterization of lymphocyte and myeloid cell infiltrates in spirocercosis-induced oesophageal nodules.
    Dvir E; Schoeman JP; Clift SJ; McNeilly TN; Mellanby RJ
    Parasite Immunol; 2011 Oct; 33(10):545-53. PubMed ID: 21770972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypovitaminosis D in dogs with spirocercosis.
    Rosa CT; Schoeman JP; Berry JL; Mellanby RJ; Dvir E
    J Vet Intern Med; 2013; 27(5):1159-64. PubMed ID: 23952621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum acute phase proteins in dogs with symptomatic esophageal spirocercosis.
    Mylonakis ME; Ceron JJ; Leontides L; Rallis TS; Koutinas AF
    Vet Parasitol; 2012 Nov; 190(1-2):191-5. PubMed ID: 22683300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple phase dynamic computed tomographic perfusion characteristics of spirocercosis induced esophageal nodules in non-neoplastic versus neoplastic canine cases.
    Kirberger RM; Cassel N; Stander N; McLean M; Dvir E
    Vet Radiol Ultrasound; 2015; 56(3):257-63. PubMed ID: 25393217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary gland enlargement and sialorrhoea in dogs with spirocercosis: a retrospective and prospective study of 298 cases.
    van der Merwe LL; Christie J; Clift SJ; Dvir E
    J S Afr Vet Assoc; 2012 Dec; 83(1):920. PubMed ID: 23327138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spirocercosis in dogs in Israel: A retrospective case-control study (2004-2009).
    Aroch I; Markovics A; Mazaki-Tovi M; Kuzi S; Harrus S; Yas E; Baneth G; Bar-El M; Bdolah-Abram T; Segev G; Lavy E
    Vet Parasitol; 2015 Jul; 211(3-4):234-40. PubMed ID: 26012861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spirocercosis in owned and stray dogs in Grenada.
    Chikweto A; Bhaiyat MI; Tiwari KP; de Allie C; Sharma RN
    Vet Parasitol; 2012 Dec; 190(3-4):613-6. PubMed ID: 22841904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spirocerca lupi induced oesophageal neoplasia: Predictors of surgical outcome.
    Pazzi P; Kavkovsky A; Shipov A; Segev G; Dvir E
    Vet Parasitol; 2018 Jan; 250():71-77. PubMed ID: 29329628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical differentiation between dogs with benign and malignant spirocercosis.
    Dvir E; Kirberger RM; Mukorera V; van der Merwe LL; Clift SJ
    Vet Parasitol; 2008 Aug; 155(1-2):80-8. PubMed ID: 18534758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and quantification of Spirocerca lupi by HRM qPCR in fecal samples from dogs with spirocercosis.
    Rojas A; Segev G; Markovics A; Aroch I; Baneth G
    Parasit Vectors; 2017 Sep; 10(1):435. PubMed ID: 28927435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed histological progression of the Spirocerca lupi-induced oesophageal lesion in dogs.
    Dvir E; Clift SJ; Williams MC
    Vet Parasitol; 2010 Feb; 168(1-2):71-7. PubMed ID: 19963322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological cross-reactivity of three commercial in-house immunoassays for detection of Dirofilaria immitis antigens with Spirocerca lupi in dogs with benign esophageal spirocercosis.
    Aroch I; Rojas A; Slon P; Lavy E; Segev G; Baneth G
    Vet Parasitol; 2015 Jul; 211(3-4):303-5. PubMed ID: 26116456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a combination of imidacloprid 10%/moxidectin 2.5% spot-on (Advocate® for dogs) in the prevention of canine spirocercosis (Spirocerca lupi).
    Le Sueur C; Bour S; Schaper R
    Parasitol Res; 2010 Nov; 107(6):1463-9. PubMed ID: 20706736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.